Commission File Number 001-31914
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
February 22, 2022
China Life Insurance Company Limited
(Translation of registrants name into English)
16 Financial Street
Xicheng District
Beijing 100033, China
Tel: (86-10) 6363-3333
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Ye ☐ No ☒
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ___________
Commission File Number 001-31914
On February 22, 2022, China Life Insurance Company Limited issued an announcement in Chinese, the English translation of which is attached as Exhibit 99.1 hereto.
EXHIBIT LIST
Exhibit | Description | |
99.1 | English translation of the announcement, dated February 22, 2022 |
Commission File Number 001-31914
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
China Life Insurance Company Limited | ||||||
(Registrant) | ||||||
By: |
/s/ Su Hengxuan | |||||
February 22, 2022 |
Name: Title: |
(Signature) Su Hengxuan President and Executive Director |
Commission File Number 001-31914
EXHIBIT 99.1
中 國 人 壽 保 險 股 份 有 限 公 司
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability)
(the Company)
(Stock Code: 2628)
Announcement on the Resolutions of the Eighth Meeting of the Seventh Session of the Board of Directors of China Life Insurance Company Limited
The eighth meeting (the Meeting) of the seventh session of the Board of Directors (the Board) of China Life Insurance Company Limited (the Company) was held on February 22, 2022 by means of written review and telecommunicating voting. The directors were notified of the Meeting by way of a written notice dated February 16, 2022. Out of the Companys ten directors, nine directors attended the Meeting. Wang Bin, executive director of the Company, was not able to attend the Meeting. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the Peoples Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Directors of the Company.
The Meeting passed the following resolutions after review and discussion:
1. | The Proposal on the Retrospective Report of the Products of the Company for Year 2021 |
Voting result: 9 for, 0 against, with no abstention
2. | The Proposal regarding Adjustment to the Composition of the Special Committees under the Seventh Session of the Board |
In accordance with relevant regulations and in consideration of the professional expertise of the independent directors and the balance of appointments, the composition of the Special Committees under the seventh session of the Board of Directors will be adjusted as follows: Mr. Lam Chi Kuen will be re-designated as the chairman of the Audit Committee and a member of the Nomination and Remuneration Committee, will continue to be a member of the Connected Transactions Control Committee, and will cease to be the chairman of the Strategy and Assets and Liabilities Management Committee. Mr. Zhai Haitao will be re-designated as the chairman of the Strategy and Assets and Liabilities Management Committee and a member of the Audit Committee, will continue to be a member of the Connected Transactions Control Committee, and will cease to be a member of the Nomination and Remuneration Committee.
Voting result: 9 for, 0 against, with no abstention
3. | The Proposal on the Authorization of the Companys Guarantee by way of Bank Credit |
Voting result: 9 for, 0 against, with no abstention
Board of Directors of China Life Insurance Company Limited
February 22, 2022